Sonic Hedgehog mimetic prevents leukocyte infiltration into the CNS during acute HIV infection
Autor: | Santhi Gorantla, Sanjay B. Maggirwar, Vir B. Singh, Dorota Piekna-Przybylska, Meera V. Singh, Larisa Y. Poluektova |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
CD4-Positive T-Lymphocytes lcsh:Medicine Inflammation HIV Infections Thiophenes Biology Blood–brain barrier Neuroprotection Article 03 medical and health sciences Mice 0302 clinical medicine medicine Leukocytes Animals Hedgehog Proteins Sonic hedgehog lcsh:Science Cells Cultured Neurons Cyclohexylamines Multidisciplinary Molecular Mimicry lcsh:R medicine.disease Leukocyte extravasation 3. Good health Chemotaxis Leukocyte 030104 developmental biology medicine.anatomical_structure Blood-Brain Barrier Astrocytes Immunology Acute Disease biology.protein Central Nervous System Viral Diseases lcsh:Q medicine.symptom Smoothened Infiltration (medical) Viral load Immunologic Memory 030217 neurology & neurosurgery Signal Transduction |
Zdroj: | Scientific Reports, Vol 7, Iss 1, Pp 1-8 (2017) Scientific Reports |
ISSN: | 2045-2322 |
DOI: | 10.1038/s41598-017-10241-0 |
Popis: | Infiltration of infected leukocytes culminates in establishment of a brain niche for Human Immunodeficiency Virus (HIV) during acute phase of infection, initiating an ongoing cascade of persistent viral replication and inflammation, that causes irreversible neuronal injury and HIV associated neurocognitive disease (HAND). In this study, humanized mice were treated with Smoothened Agonist (SAG), a Sonic Hedgehog (Shh) mimetic in order to fortify blood brain barrier (BBB) and dampen leukocyte extravasation into CNS during AHI. Results indicate that SAG treatment reduced viral burden in the CNS immediately after HIV transmission, but also conferred extended neuroprotection via increased BBB integrity (elevated levels of tight-junction protein, Claudin 5, and reduced S100B levels in periphery). These mice also showed healthier neurons with thick, uniform dendrites and reduced numbers of activated astrocytes. Additional in vitro experiments suggested SAG treatment was not associated with the establishment or reversal of latency in the target cells. Altogether, these findings validate neuroprotective role of Shh signaling and highlight the therapeutic potential of Shh mimetics against CNS complications associated with HIV infection. Further our results strongly demonstrate that pharmacological interventions to reduce leukocyte mobilization during early HIV infection, can provide prolonged neuroprotection, which might significantly delay the onset of HAND. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |